<qa>  What is the name of the procedure that enrolled subjects will undergo?Following consent, enrolled subjects will undergo a leukapheresis procedure to collect autologous mononuclear cells for manufacture of investigational drug product bb2121. Following manufacture of the drug product, subjects will receive lymphodepletion prior to bb2121 infusion. All subjects will then be followed for up to 24 months in Study CRB-401. 